Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

New genetic classifier can predict the sensitivity of neoadjuvant chemotherapy for breast cancer

New genetic classifier can predict the sensitivity of neoadjuvant chemotherapy for breast cancer

Leducq Foundation awards $7 million for vascular malformation research

Leducq Foundation awards $7 million for vascular malformation research

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Cancer chemotherapy changes the function of cells that repair heart injury

Cancer chemotherapy changes the function of cells that repair heart injury

Gene could predict treatment response in certain breast cancer patients

Gene could predict treatment response in certain breast cancer patients

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Researchers identify protein that plays critical role in cancer treatment-related heart damage

Researchers identify protein that plays critical role in cancer treatment-related heart damage

Statins may protect against heart damage caused by breast cancer therapies

Statins may protect against heart damage caused by breast cancer therapies

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Yale study highlights the need to develop effective, less toxic approaches to treat AML patients

Yale study highlights the need to develop effective, less toxic approaches to treat AML patients

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cardiac resynchronization therapy improves heart function in cancer survivors

Cardiac resynchronization therapy improves heart function in cancer survivors

Nab-Paclitaxel drug combo reduces risk of  breast cancer recurrence

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence